<DOC>
	<DOCNO>NCT02100605</DOCNO>
	<brief_summary>Phytosun decongestant nasal spray class I medical device register European Union treatment nasal congestion . The spray contain hypertonic seawater essential oil . The objective study investigate effect nasal spray , register medical device name Phytosun Decongestant European Union , speed onset relief nasal congestion 50 subject suffer nasal congestion associate common cold .</brief_summary>
	<brief_title>Study Hypertonic Saline Nasal Spray</brief_title>
	<detailed_description>The study also include exploratory assessement objective change nasal patency measure nasal peak inspiratory flow treatment .</detailed_description>
	<mesh_term>Nasal Decongestants</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<criteria>1 . Aged18 year 2 . Has give write informed consent , receive copy sign consent form prior study related procedure 3 . Subject considers suffer common cold 7 day duration ( common cold selfdiagnosed patient screen doctor nasal examination perform need establish eligibility patient study ) . 4 . Subject entry study symptom score 1 great block nose four point ordinal scale 1 . Have know hypersensitivity allergic component test product 2 . The subject clinically significant cardiovascular , endocrinological , neurological , respiratory , gastrointestinal disease history current disease consider investigator reason exclusion e.g . current allergic rhinitis , chronic obstructive pulmonary disease 3 . The subject severe nasal septal deviation condition could cause nasal obstruction presence nasal polyp . 4 . The subject nasal sinus surgery past opinion investigator may influence symptom score 5 . The subject history alcohol substance abuse previous year 6 . The subject take prescribed medication contraception , consider investigator reason exclusion e.g . systemic steroid , intranasal medicine , antibiotic . 7 . The subject common cold flu like symptom seven day 8 . The subject recently take common cold medicine opinion investigator may influence baseline symptom score ( nasal decongestant ) 9 . The subject current smoker ( 2 cigarette , pipe , cigar day ) 10 . The subject relate study personnel 11 . The subject receive investigational drug participate clinical trial within 4 week entry study 12 . The subject pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Nasal</keyword>
	<keyword>Congestion</keyword>
	<keyword>Decongestion</keyword>
	<keyword>Hypertonic</keyword>
	<keyword>Saline solution</keyword>
</DOC>